Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses-Reference-Cited by-同舟云学术

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Zhou Runhong¹²,To Kelvin Kai‐Wang²³⁴⁵,Peng Qiaoli¹²⁶,Chan Jacky Man‐Chun⁷,Huang Haode¹,Yang Dawei¹,Lam Bosco Hoi‐Shiu⁸,Chuang Vivien Wai‐Man⁹,Cai Jian‐Piao²,Liu Na¹²,Au Ka‐Kit¹,Tsang Owen Tak‐Yin⁷,Yuen Kwok‐Yung²³⁴⁵,Chen Zhiwei¹²³⁴⁵^ORCID

Affiliation:

1. AIDS Institute, Li Ka Shing Faculty of Medicine University of Hong Kong Pokfulam Hong Kong Special Administrative Region People's Republic of China

2. Department of Microbiology Li Ka Shing Faculty of Medicine University of Hong Kong Pokfulam Hong Kong Special Administrative Region People's Republic of China

3. State Key Laboratory for Emerging Infectious Diseases University of Hong Kong Pokfulam Hong Kong Special Administrative Region People's Republic of China

4. Centre for Virology, Vaccinology and Therapeutics Limited University of Hong Kong Hong Kong Special Administrative Region People's Republic of China

5. Department of Clinical Microbiology and Infection Control University of Hong Kong‐Shenzhen Hospital Shenzhen Guangdong People's Republic of China

6. National Clinical Research Center for Infectious Diseases The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology Shenzhen Guangdong People's Republic of China

7. Department of Medicine and Geriatrics Princess Margaret Hospital Hong Kong Special Administrative Region People's Republic of China

8. Department of Pathology Princess Margaret Hospital Princess Margaret Hospital Hong Kong Special Administrative Region People's Republic of China

9. Quality & Safety Division Hospital Authority Hong Kong Special Administrative Region People's Republic of China

Funder

Health and Medical Research Fund

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.720

Reference10 articles.

1. GISAID: Global initiative on sharing all influenza data – from vision to reality

2. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

3. Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

4. Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19

5. Waning immune responses against SARS‐CoV‐2 among vaccinees in Hong Kong;Peng Q;bioRxiv,2021

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: an update;Minerva Medica;2023-11

2. In-hospital clinical course, outcome and complications among patients vaccinated against COVID-19;Proceedings of the National Academy of Sciences of Belarus, Medical series;2023-03-02

3. Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong;The Lancet Regional Health - Western Pacific;2023-03

4. COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates;Journal of Epidemiology and Global Health;2023-02-16

5. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern;npj Vaccines;2023-02-13